WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles:
Related suggestion:
'Wearing garden on the head' in Fujian attracts visitorsTory rebels urge Rishi Sunak to ditch controversial smoking ban plan and other 'fundamentally unStop prescribing puberty blockers to children168 tombs unearthed in China's ShandongBritish jets shoot down Iranian drones over Syrian borderTory rebels urge Rishi Sunak to ditch controversial smoking ban plan and other 'fundamentally un76ers play their season finale without AllDetermined language major from Russia helps bridge bilateral exchangesJoel Cauchi: New details emerge about Bondi Junction knifeman that killed sixSpring Festival TV gala to delight global audience with traditional culture, cutting
2.3002s , 6496.796875 kb
Copyright © 2024 Powered by Vertex Pharma scientist talks about the long road to developing non ,Stellar Stance news portal